Medical Device Developer and Manufacturer

This integrated medical technology company is primarily dedicated to the development and manufacturing of osteosynthesis products. (These products include bone, skull, spine and other implants.) There is also a smaller division (approximately 10% of revs/profits) that develops and produces biomedical treatments such as stem cell therapies. 2021 revenues were $34.5 MMUSD and ebitda was $11.1 MMUSD. The company is growing and has strong demand and ability to export.